How much is the Musculoskeletal Drugs Market market?

The musculoskeletal drugs market market size is estimated to grow at $$ 26370.8 mn in 2023. Read More

What is the growth rate of the Musculoskeletal Drugs Market market?

The growth rate of the musculoskeletal drugs market year-over-year is 5.8%. Read More

Which region held the largest market share in the Musculoskeletal Drugs Market market?

North America is the region to held the largest market share with 32% growth. Read More

Who are the key players in the Musculoskeletal Drugs Market market?

AbbVie Inc., Amgen Inc., Anika Therapeutics Inc., Astellas Pharma Inc., Bioventus LLC, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., .... Read More

Which Segment has the largest market share in the Musculoskeletal Drugs Market market?

Drug Class is the segment that has the largest market share in the market. Read More

Musculoskeletal Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, Japan, UK, India, France, Brazil, Canada, Australia - Size and Forecast 2024-2028

Published: Oct 2024
Pages: 210
SKU: IRTNTR80253

Enjoy complimentary customisation on priority with our Enterprise License!

Musculoskeletal Drugs Market Size 2024-2028

The musculoskeletal drugs market size is forecast to increase by USD 26.37 billion at a CAGR of 5.8% between 2023 and 2028. The market is experiencing significant growth due to several key trends and challenges. One of the primary drivers is the increasing prevalence of musculoskeletal pain, particularly among the aging population. Smooth muscle relaxants, such as Carisoprodol, Chlorzoxazone, Cyclobenzaprine, and Metaxalone, continue to be popular treatments for musculoskeletal pain. However, the high treatment costs associated with these prescription generic drugs have led to an increase in the adoption of over-the-counter (OTC) alternatives, such as Acetaminophen, as a more cost-effective solution. Another trend in the market is the adoption of artificial intelligence (AI) and machine learning (ML) technologies for diagnosing musculoskeletal conditions, which can help improve accuracy and reduce healthcare costs. Despite these trends, the high treatment costs remain a significant challenge for the market, and efforts are being made to develop more affordable treatment options to meet the growing demand.

What will be the Size of the Market During the Forecast Period?

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value Chain Analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2023

4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

5.1 Global Musculoskeletal Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Musculoskeletal Drugs Market 2018 - 2022 ($ million)

5.2 Drug Class segment analysis 2018 - 2022
- Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)

5.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)

5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on the Global Musculoskeletal Drugs Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Drug Class

8.1 Market segments
- Chart on Drug Class - Market share 2023-2028 (%)
- Data Table on Drug Class - Market share 2023-2028 (%)

8.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class

8.3 Nonsteroidal anti inflammatory drugs - Market size and forecast 2023-2028
- Chart on Nonsteroidal anti inflammatory drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Nonsteroidal anti inflammatory drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Nonsteroidal anti inflammatory drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Nonsteroidal anti inflammatory drugs - Year-over-year growth 2023-2028 (%)

8.4 Disease modifying anti rheumatic drugs - Market size and forecast 2023-2028
- Chart on Disease modifying anti rheumatic drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Disease modifying anti rheumatic drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Disease modifying anti rheumatic drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Disease modifying anti rheumatic drugs - Year-over-year growth 2023-2028 (%)

8.5 Analgesics - Market size and forecast 2023-2028
- Chart on Analgesics - Market size and forecast 2023-2028 ($ million)
- Data Table on Analgesics - Market size and forecast 2023-2028 ($ million)
- Chart on Analgesics - Year-over-year growth 2023-2028 (%)
- Data Table on Analgesics - Year-over-year growth 2023-2028 (%)

8.6 Corticosteroids - Market size and forecast 2023-2028
- Chart on Corticosteroids - Market size and forecast 2023-2028 ($ million)
- Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ million)
- Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
- Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)

8.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)

8.8 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)

9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel

9.3 Hospital pharmacy - Market size and forecast 2023-2028
- Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)

9.4 Retail pharmacy - Market size and forecast 2023-2028
- Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)

9.5 Online pharmacy - Market size and forecast 2023-2028
- Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)

9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

11.10 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)

11.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

11.12 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)

11.13 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)

11.14 Brazil - Market size and forecast 2023-2028
- Chart on Brazil - Market size and forecast 2023-2028 ($ million)
- Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
- Chart on Brazil - Year-over-year growth 2023-2028 (%)
- Data Table on Brazil - Year-over-year growth 2023-2028 (%)

11.15 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

11.16 Australia - Market size and forecast 2023-2028
- Chart on Australia - Market size and forecast 2023-2028 ($ million)
- Data Table on Australia - Market size and forecast 2023-2028 ($ million)
- Chart on Australia - Year-over-year growth 2023-2028 (%)
- Data Table on Australia - Year-over-year growth 2023-2028 (%)

11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers

12.2 Market challenges

12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview

13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

13.3 Landscape disruption
- Overview on factors of disruption

13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered

14.2 Company ranking index
- Company ranking index

14.3 Market positioning of companies
- Matrix on companies position and classification

14.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT

14.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT

14.6 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT

14.7 Bioventus LLC
- Bioventus LLC - Overview
- Bioventus LLC - Business segments
- Bioventus LLC - Key news
- Bioventus LLC - Key offerings
- Bioventus LLC - Segment focus
- SWOT

14.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT

14.9 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT

14.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT

14.11 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- SWOT

14.12 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT

14.13 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT

14.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT

14.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT

14.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT

14.17 UCB SA
- UCB SA - Overview
- UCB SA - Product / Service
- UCB SA - Key offerings
- SWOT

14.18 Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. - Overview
- Zimmer Biomet Holdings Inc. - Business segments
- Zimmer Biomet Holdings Inc. - Key news
- Zimmer Biomet Holdings Inc. - Key offerings
- Zimmer Biomet Holdings Inc. - Segment focus
- SWOT

15 Appendix